Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Profitable Stocks We’re Skeptical Of

2026-08-12
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Option Care Health (OPCH) Q2 2026 Earnings Call Transcript

2026-08-08
CID census stabilizes as facility-based nursing expands and AI tools drive operational efficiency.

OPCH vs. PNTG: Which Stock Is the Better Value Option?

2026-08-07
OPCH vs. PNTG: Which Stock Is the Better Value Option?

Madison Small Cap Fund Q2 2026 Portfolio Activity

2026-08-05
Madison Small Cap Fund shares Q2 2026 portfolio shifts, exiting SMPL and OSW while adding INDI and BDC. Read the full analysis for more details.

Is Option Care Health (OPCH) Stock Undervalued Right Now?

2026-08-05
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Option Care Health (NASDAQ:OPCH): A Decent Value Stock with an Attractive Valuation

2026-08-05
Option Care Health (OPCH) offers a compelling value play with a low P/E, solid profitability, and positive growth despite moderate debt.

BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth

2026-08-04
BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.

Is BTSG a Buy as Rapid Growth Collides With Its Premium Valuation?

2026-08-04
BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation leaves little room for execution missteps.

BTSG Drops 18.1% in One Week as Growth Meets Fresh Valuation Risks

2026-08-04
BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, policy and integration risks test the rebound case.

OPCH Q2 Deep Dive: Execution on Acute and Chronic Portfolios Drives Outperformance

2026-08-01
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 1.9% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.73 billion, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 5.4% above analysts’ consensus estimates.